ISSN2320-2882
Impact Factor9.17
UGC ParametersAligned
Low Cost₹1501 / $59
CrossRefDOI
ESTD2013
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

REPORT ON DRUG REGULATORY AFFAIRS

Authors

Mr. Vaibhav Narwade , Ms. Snehal Somnath Shinde , Dr. VijayKumar Kale , Dr. Mahesh Thakare

Keywords

Drug Regulatory Affairs, USFDA, EMA, CDSCO, ICH Guidelines, Biosimilars, Generics, Pharmacovigilance, Clinical Trials, Regulatory Pathways, CTD, NDA, ANDA, Drug Approval.

Abstract

Drug Regulatory Affairs (DRA) is essential to guaranteeing their effectiveness, safety, and quality. Drug regulation must change to accommodate new technologies like biotechnology, nanomedicine, gene therapy, and biosimilars as the pharmaceutical industry changes due to quick scientific breakthroughs. The USFDA, EMA, CDSCO, MHRA, PMDA, and TGA are just a few of the key regulators that are highlighted in this thorough review of the world's drug regulatory systems. Additionally, it looks at how the International Council for Harmonisation (ICH) has contributed to regulatory convergence by establishing uniform standards for efficacy, safety, and quality. The paper also goes into detail on different drug approval regulatory paths, including IND, NDA, ANDA, BLA, biosimilar approvals, fast-track authorizations, and emergency use authorizations. Special focus is paid to generic medications, biosimilars, and interchangeability principles, which greatly affect healthcare affordability and accessibility. The issues encountered by regulatory authorities--such as rising complexity of clinical trials, worldwide harmonization gaps, ethical concerns, and delays in approvals--are critically reviewed. The report delves deeper into the future of drug regulation, forecasting a move towards Blockchain-enabled supply chain monitoring, digital regulatory systems, AI-assisted assessments, and adaptive clinical trial designs. In general, the study highlights how crucial robust regulatory regimes are for advancing public health, fostering innovation, and guaranteeing that everyone has access to safe and effective medications.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJCRT — journal style
"REPORT ON DRUG REGULATORY AFFAIRS", IJCRT - International Journal of Creative Research Thoughts (www.ijcrt.org), ISSN:2320-2882, Vol.13, Issue 12, page no.g122-g129, December 2025, Available :https://ijcrt.org/papers/IJCRT2512682.pdf
APA — 7th edition
Narwade, V., Shinde, S. S., Kale, V., & Thakare, M. (2025). REPORT ON DRUG REGULATORY AFFAIRS. International Journal of Creative Research Thoughts, 13(12), g122-g129. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682
MLA — 9th edition
Narwade, Vaibhav, et al. "REPORT ON DRUG REGULATORY AFFAIRS." International Journal of Creative Research Thoughts, vol. 13, no. 12, 2025, pp. g122-g129, https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682.
Chicago — 17th, bibliography
Narwade, Vaibhav, et al. "REPORT ON DRUG REGULATORY AFFAIRS." International Journal of Creative Research Thoughts 13, no. 12 (2025): g122-g129. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682.
Harvard — author–date
Narwade, V. et al. (2025) 'REPORT ON DRUG REGULATORY AFFAIRS', International Journal of Creative Research Thoughts, 13(12), pp. g122-g129. Available at: https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682
IEEE — numbered reference
V. Narwade, S. S. Shinde, V. Kale and M. Thakare, "REPORT ON DRUG REGULATORY AFFAIRS," IJCRT, vol. 13, no. 12, pp. g122-g129, Dec. 2025.
Vancouver — biomedical
Narwade V, Shinde SS, Kale V, Thakare M. REPORT ON DRUG REGULATORY AFFAIRS. IJCRT. 2025 Dec;13(12):g122-g129.
AMA — 11th edition
Narwade V, Shinde SS, Kale V, Thakare M. REPORT ON DRUG REGULATORY AFFAIRS. IJCRT. 2025;13(12):g122-g129. Accessed at https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682
BibTeX — Zotero, Mendeley, LaTeX
@article{IJCRT2512682, author = {Vaibhav Narwade and Snehal Somnath Shinde and VijayKumar Kale and Mahesh Thakare}, title = {REPORT ON DRUG REGULATORY AFFAIRS}, journal = {International Journal of Creative Research Thoughts}, volume = {13}, number = {12}, pages = {g122-g129}, year = {2025}, month = {December}, issn = {2320-2882}, url = {https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682} }
RIS — EndNote, RefWorks
TY - JOUR AU - Narwade, Vaibhav AU - Shinde, Snehal Somnath AU - Kale, VijayKumar AU - Thakare, Mahesh TI - REPORT ON DRUG REGULATORY AFFAIRS T2 - International Journal of Creative Research Thoughts JA - IJCRT VL - 13 IS - 12 PY - 2025 SN - 2320-2882 UR - https://ijcrt.org/viewpaperforall.php?paper=IJCRT2512682 SP - g122-g129 ER -

Issue

Volume 13 Issue 12, December-2025
Pages : g122-g129

Article Information

Pages
g122-g129
Published
December 2025
Registration ID
IJCRT_299190
Published Paper ID
IJCRT2512682
Research Area
Science and Technology
Author Type
Indian Author
Location
India
Licence
CC BY 4.0 · Open Access
ISSN & Impact Factor
2320-2882 · IF 9.17
Downloads
193

Summarise this Paper with AI

Opens your assistant with a prepared prompt. AI summaries can be incomplete or wrong — read the full paper before citing it.

Share This Article

Author Services

Certificates, printed copies and official reports for this paper

Published authors can request a hard copy of their certificate or of the printed journal, and obtain the transparent peer review and plagiarism reports for this article — each issued against this paper’s registration record.

Registration ID IJCRT_299190

About Publisher

International Journal of Creative Research Thoughts Published by IJCRT Publication
2320-2882 ISSN
9.17 Impact Factor
2013 ESTD Year
Open Access
Impact Factor 9.17, calculated from Google Scholar citation data — see how it is worked out.
An international scholarly open access journal: peer-reviewed, refereed, multidisciplinary, monthly and multilingual, with Crossref DOI registration, rich metadata and a citation generator. Verified indexing & discovery records.
IJCRT is a Transparent, Peer-Reviewed, Open Access Journal (Refereed Journal). Following the discontinuation of UGC and UGC-CARE journal listing, IJCRT is aligned with UGC’s Suggested Parameters for Choosing Peer-Reviewed Journals. UGC Public Notice

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal of Creative Research Thoughts for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

About the Journal
9.17Impact Factor UGC AlignedSuggested Parameters TransparentPeer Review
Open AccessNo Paywall
CrossrefDOI Available
Monthly12 Issues / Year
Since 2013Established
2320-2882ISSN

Article Impact

64Views
56Downloads
120Total reads
Dec 2025Published
Published · 298 days ago Today · last read today
120 TOTAL
Views 64Downloads 56
88%
Readers who went on to take the PDF
Abstract views64
PDF downloads56

2.2 views and 1.9 downloads per day over 29 days counted.

Counts exclude identified crawler traffic and repeat hits from the same reader within 30 minutes. Downloads reached directly through a search engine or an existing citation link are not included, so the figure is a conservative count of activity through this site. Full statistics

Discovery & Indexing

Find this paper on search engines and scholarly indexes, and check the journal’s verified records.

Find this paperSearch
  • Google ScholarExact-title search, with citing articles once indexed.Search
  • CrossrefMetadata search across all Crossref records.Search
  • Semantic ScholarAI-powered literature search.Search
  • BASEBielefeld Academic Search Engine — open-access harvester.Search
  • ResearchGateResearch network publication search.Search

“Search” opens a live search for this paper; “Verified” opens a journal record checked on the Indexing & Discovery page. Third-party services index at their own discretion, often several weeks after publication.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹1501
Publish in a UGC CARE Approved Journal | Low Cost ₹1501 Indian Author | 🌐 $59 USD International
CrossRef DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →